Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaochaihu Granules for Depression After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07608029Phase 2Not yet recruiting
- Start
- May 2026
- Primary completion
- Aug 2026
01
Overview
A Phase 2 trial of Xiaochaihu Granules in major depressive disorder (MDD). Planned start May 2026; status: not yet recruiting.
02
Drugs
Xiaochaihu Granules
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07608029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07608029.